Patricia Melnyk

2.3k total citations
91 papers, 1.7k citations indexed

About

Patricia Melnyk is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Patricia Melnyk has authored 91 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 39 papers in Organic Chemistry and 11 papers in Pharmacology. Recurrent topics in Patricia Melnyk's work include Pharmacological Receptor Mechanisms and Effects (17 papers), Receptor Mechanisms and Signaling (15 papers) and Synthesis and biological activity (10 papers). Patricia Melnyk is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (17 papers), Receptor Mechanisms and Signaling (15 papers) and Synthesis and biological activity (10 papers). Patricia Melnyk collaborates with scholars based in France, Belgium and United States. Patricia Melnyk's co-authors include Christian Sergheraert, Philippe Grellier, Philippe Cotelle, Vincent Leroux, Fabrice Bailly, Guillemette Huet, Alexandre Barras, Antoine Richard, Adina Ryckebusch and Stéphane Roux and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Journal of Virology.

In The Last Decade

Patricia Melnyk

86 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patricia Melnyk France 20 781 689 311 177 118 91 1.7k
Parvinder Pal Singh India 27 1.3k 1.7× 835 1.2× 184 0.6× 83 0.5× 99 0.8× 104 2.4k
Andreas Link Germany 24 813 1.0× 1.4k 2.0× 113 0.4× 205 1.2× 136 1.2× 121 2.3k
Alberto Massarotti Italy 24 1.1k 1.5× 862 1.3× 73 0.2× 210 1.2× 105 0.9× 64 2.3k
Carlos Maurício R. Sant’Anna Brazil 22 714 0.9× 890 1.3× 93 0.3× 339 1.9× 214 1.8× 98 1.7k
Rosanna Maccari Italy 31 1.6k 2.0× 950 1.4× 426 1.4× 253 1.4× 87 0.7× 55 2.6k
John P. Mallamo United States 29 1.1k 1.4× 1.1k 1.6× 132 0.4× 272 1.5× 235 2.0× 64 2.3k
Donald S. Karanewsky United States 30 1.1k 1.4× 1.8k 2.6× 148 0.5× 362 2.0× 100 0.8× 77 3.0k
Rajesh Devraj United States 20 746 1.0× 951 1.4× 108 0.3× 218 1.2× 382 3.2× 35 1.9k
Marco L. Lolli Italy 22 386 0.5× 563 0.8× 143 0.5× 76 0.4× 69 0.6× 67 1.2k
Paolo Ruzza Italy 23 384 0.5× 917 1.3× 179 0.6× 142 0.8× 54 0.5× 110 2.0k

Countries citing papers authored by Patricia Melnyk

Since Specialization
Citations

This map shows the geographic impact of Patricia Melnyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Melnyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Melnyk more than expected).

Fields of papers citing papers by Patricia Melnyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Melnyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Melnyk. The network helps show where Patricia Melnyk may publish in the future.

Co-authorship network of co-authors of Patricia Melnyk

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Melnyk. A scholar is included among the top collaborators of Patricia Melnyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Melnyk. Patricia Melnyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ravez, Séverine, Didier Vertommen, Nicolas Renault, et al.. (2025). LIBX‐A401: A Novel Selective Inhibitor of Acyl‐CoA Synthetase Long Chain Family Member 4 (ACSL4) and Its Binding Mode. Angewandte Chemie. 137(19). 2 indexed citations
2.
Ravez, Séverine, Didier Vertommen, Nicolas Renault, et al.. (2025). LIBX‐A401: A Novel Selective Inhibitor of Acyl‐CoA Synthetase Long Chain Family Member 4 (ACSL4) and Its Binding Mode. Angewandte Chemie International Edition. 64(19). e202500518–e202500518. 4 indexed citations
3.
Renault, Nicolas, Aurélie Jonneaux, Jean‐Christophe Devedjian, et al.. (2025). Discovery of Potent Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4) Inhibitors with Antiferroptotic Properties. Journal of Medicinal Chemistry. 68(15). 15766–15784. 1 indexed citations
4.
Ordóñez, Antonio Jesús Lara, et al.. (2024). Leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson’s disease: a patent review of the literature to date. Expert Opinion on Therapeutic Patents. 34(9). 773–788. 7 indexed citations
5.
6.
Rapetti‐Mauss, Raphaël, Jérémy Nigri, Pascal Finetti, et al.. (2022). SK2 channels set a signalling hub bolstering CAF-triggered tumourigenic processes in pancreatic cancer. Gut. 72(4). 722–735. 11 indexed citations
7.
Ravez, Séverine, Eloïse Woitrain, Pascal Odou, et al.. (2022). Safe and Efficient Sigma1 Ligand: A Potential Drug Candidate for Multiple Sclerosis. International Journal of Molecular Sciences. 23(19). 11893–11893. 2 indexed citations
8.
Ravez, Séverine, Karine Porte, Jean-Christophe Devedjian, et al.. (2022). Repositioning of FDA-Approved antifungal agents to interrogate Acyl-CoA synthetase long chain family member 4 (ACSL4) in ferroptosis. Biochemical Pharmacology. 204. 115239–115239. 12 indexed citations
9.
Mésangeau, Christophe, et al.. (2021). Pharmacomodulations around an anti-Alzheimer drug-candidate. SHILAP Revista de lepidopterología. 4. 100020–100020.
10.
Jonckheere, Nicolas, et al.. (2020). EGF-Containing Membrane-Bound Mucins: A Hidden ErbB2 Targeting Pathway?. Journal of Medicinal Chemistry. 63(10). 5074–5088. 12 indexed citations
11.
Naour, Morgan Le, Pascal Carato, Patricia Melnyk, et al.. (2020). Effect of 6-Benzoyl-benzothiazol-2-one scaffold on the pharmacological profile of α-alkoxyphenylpropionic acid derived PPAR agonists. Journal of Enzyme Inhibition and Medicinal Chemistry. 35(1). 524–538. 4 indexed citations
12.
Caignard, Daniel H., et al.. (2020). Quinazoline and phthalazine derivatives as novel melatonin receptor ligands analogues of agomelatine. European Journal of Medicinal Chemistry. 189. 112078–112078. 12 indexed citations
13.
Magnez, Romain, Xavier Thuru, Séverine Ravez, et al.. (2019). MUC4-ErbB2 Oncogenic Complex: Binding studies using Microscale Thermophoresis. Scientific Reports. 9(1). 16678–16678. 10 indexed citations
14.
15.
Donnier‐Maréchal, Marion, et al.. (2014). Carboline- and phenothiazine-derivated heterocycles as potent SIGMA-1 protein ligands. European Journal of Medicinal Chemistry. 89. 198–206. 17 indexed citations
16.
Gozalbes, Rafael, et al.. (2013). Hit identification of novel heparanase inhibitors by structure- and ligand-based approaches. Bioorganic & Medicinal Chemistry. 21(7). 1944–1951. 17 indexed citations
17.
Melnyk, Patricia, et al.. (2010). Optimized and convergent synthesis of potent anti-malarial aminoquinoline compounds: easy access to analogs. Heterocyclic Communications. 16(4-6). 235–239. 1 indexed citations
18.
Grellier, Philippe, et al.. (2007). Synthesis and antimalarial activity of carbamate and amide derivatives of 4-anilinoquinoline. European Journal of Medicinal Chemistry. 43(10). 2045–2055. 15 indexed citations
19.
Ryckebusch, Adina, et al.. (2004). Synthesis and antimalarial evaluation of new N1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine derivatives. Bioorganic & Medicinal Chemistry Letters. 15(2). 297–302. 34 indexed citations
20.
Melnyk, Patricia, et al.. (1993). Heck reaction to a new heterocyclic system: pyrido[2′,3′-dt]pyridazino[2,3-a]indole. Tetrahedron Letters. 34(34). 5449–5450. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Parvinder Pal Singh Breakdown of academic impact, for papers by Andreas Link Breakdown of academic impact, for papers by Alberto Massarotti Breakdown of academic impact, for papers by Carlos Maurício R. Sant’Anna Breakdown of academic impact, for papers by Rosanna Maccari Breakdown of academic impact, for papers by John P. Mallamo Breakdown of academic impact, for papers by Donald S. Karanewsky Breakdown of academic impact, for papers by Rajesh Devraj Breakdown of academic impact, for papers by Marco L. Lolli Breakdown of academic impact, for papers by Paolo Ruzza
Rankless by CCL
2026